MYC and neoplasm: These genetic alterations include hypermethylation of the Glutathione S-transferase P1 (GSTP1) promoter, the stimulation of the proto-oncogene Myc, and deletions of regions protecting recognized tumor suppressors on chromosome 10q23 such as phosphatase and tensin homolog (PTEN) [36,37].